Two decades of pediatric celiac disease in a tertiary referral center: What has changed?

Alexander Krauthammer1, Anat Guz-Mark2, Noam Zevit2

  • 1Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Israel.

Insights

Pediatric celiac disease (CD) presentation has shifted towards milder symptoms and asymptomatic cases. Recent decades show improved gluten-free diet adherence and faster serology normalization in children with CD.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Clinical Medicine

Background:

  • Celiac disease (CD) is a prevalent global autoimmune disorder.
  • The presentation and management of CD are evolving over time.

Purpose of the Study:

  • To analyze shifts in pediatric celiac disease presentation and management over two decades.
  • To compare clinical and laboratory findings between early and late study periods.

Main Methods:

  • Retrospective chart review of 932 pediatric celiac disease patients (1999-2018).
  • Comparison of presentation and follow-up data between two 10-year periods (1999-2008 vs. 2009-2018).

Main Results:

  • Patients in the later decade showed lower rates of weight loss and abdominal distention.
  • Increased abdominal pain and asymptomatic presentations were noted in the later decade.
  • Improved gluten-free diet adherence and faster celiac serology normalization were observed in recent years.

Conclusions:

  • Children with celiac disease are increasingly diagnosed with milder symptoms.
  • Enhanced adherence to gluten-free diets contributes to better outcomes.
  • Earlier normalization of celiac serology is achievable with current management strategies.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
146
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
184
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
242
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
565
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
159
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
605